文献速递疝与腹壁外科肝胆胰外科围术期管理与 ERAS

肝移植后腹腔镜切口疝修补术的安全性:单中心对比研究

Safety of laparoscopic incisional hernia repair after liver transplant: a comparative study from a single institution.
PubMed 文献 · Surg Endosc · 2026-05-26

本研究回顾性比较肝移植受者与非移植患者接受腹腔镜切口疝修补术的安全性,肝移植组并发症和手术部位事件发生率更高,但感染、复发和再入院率无显著差异,无30天死亡。

要点

  • 肝移植受者腹腔镜切口疝修补术后总体并发症和手术部位事件发生率更高。
  • 倾向评分匹配后肝移植组手术部位事件仍更高,但感染、复发和再入院无差异。
  • 肝移植受者手术部位事件增加可能源于合并症和疝复杂性而非手术技术。

核心结论

  • 肝移植受者行腹腔镜切口疝修补术安全有效,感染、复发和再入院率与非移植患者相当。

研究设计与样本

  • 单中心回顾性队列研究,纳入147例患者(肝移植42例,非肝移植105例),采用1:1倾向评分匹配调整年龄、性别、BMI、糖尿病、高血压、血脂异常和慢性肾病。

主要发现

  • 肝移植组总体并发症发生率35.7% vs 非移植组13.3%(p=0.0006),手术部位事件19.0% vs 6.7%(p=0.035)。
  • 匹配后肝移植组手术部位事件发生率仍更高(19.0% vs 2.4%,p=0.029),但手术部位感染、复发和再入院无显著差异。
  • 两组均无30天死亡。

关键数值与推荐

  • 肝移植组糖尿病率38.1% vs 14.3%,慢性肾病率42.9% vs 0.07%,疝缺损中位面积120 cm2 vs 27.5 cm2(p<0.001)。
  • 肝移植组手术时间中位116 min vs 95 min,住院时间中位3.0天 vs 1.0天。
  • 中位临床随访0.6个月(IQR 0.5-1.5),通过完整电子病历回顾至2025年初识别晚期事件和潜在复发。

临床怎么用

  • 肝移植受者行腹腔镜切口疝修补术需仔细选择患者并优化围术期管理。
  • 肝移植受者术后应关注手术部位事件,尤其是合并糖尿病和慢性肾病者。

局限性

  • 回顾性单中心设计,样本量有限,随访时间较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Ventral incisional hernia (VIH) is a frequent complication after liver transplantation (LT), with incidence rates up to 46%. Repair in LT recipients is particularly challenging due to immunosuppression, comorbidities, and large hernia defects. While laparoscopic incisional hernia repair (LIHR) has shown advantages in the general population, comparative outcomes in LT patients remain underexplored. This study evaluates the safety and short-term outcomes of LIHR in LT recipients versus non-transplant patients. METHODS: A retrospective cohort study was conducted of patients undergoing LIHR at a single institution. LT recipients (2016-2025) were compared to non-transplant patients (2020-2022). Demographics, comorbidities, operative variables, and postoperative outcomes-including surgical site occurrences (SSO), infections (SSI), recurrence, readmissions, and mortality-were analyzed. Propensity score matching (1:1) adjusted for baseline differences in age, gender, BMI, diabetes, hypertension, dyslipidemia, and chronic kidney disease. RESULTS: A total of 147 patients were included (42 LT; 105 non-LT). LT recipients were older, had higher rates of diabetes (38.1 vs. 14.3%) and chronic kidney disease (42.9 vs. 0.07%), and presented with larger hernia defects (median 120 vs. 27.5 cm2; p < 0.001). Operative time and length of stay were significantly longer in LT patients (116 vs. 95 min; 3.0 vs. 1.0 days). Median clinical follow-up was 0.6 months (IQR 0.5-1.5), with late events and potential recurrences identified through complete EMR review through early 2025. Complication rates were higher in LT recipients (35.7 vs. 13.3%; p = 0.0006), particularly SSOs (19.0 vs. 6.7%; p = 0.035). After matching, LT recipients still exhibited higher SSO rates (19.0 vs. 2.4%; p = 0.029), but no significant differences were found in SSI, recurrence, or readmissions. No 30-day mortality occurred in either group. CONCLUSIONS: LIHR in LT recipients is safe and effective, with comparable rates of infection, recurrence, and readmission to non-transplant patients. Increased SSOs in LT patients appear primarily driven by comorbidities and hernia complexity rather than surgical technique. Careful patient selection and perioperative optimization remain essential.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Altolaguirre A, Cobos MS, Bashiri A, et al. Safety of laparoscopic incisional hernia repair after liver transplant: a comparative study from a single institution. Surg Endosc. 2026. PMID: 42191955. doi:10.1007/s00464-026-12815-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。